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oxygen is required for its further metabolism. • 
• P~QTO~QIU'l{'P.!~i III {9a). 
Protoporpeyrin III (9a) is the key porphyrin in 
both animals and plants as from t his , haem and chloro-
78 
pbyll are derived. It is formed from copro~orphyrinogen 
III (142,143.346) and its fonnati~n involves to 
stages:-
(1) The oxidative decarbo:xylation of two pro:pionic 
side chains to vinyl groups to form protoporpbyrinoten. 
(2) ~he oxidation of the protoporpbyrinogen to 
protoporpbyrin III (9a). the precursor of haem. 
J 
Reaction {l) is catalyzed by the enzyme copropor-
phyrinogen oxidative decarboxylase (346) also termed 
co1>ropopbyringen oxidase by ano and Gra.nick { 375) • 
For the purposes of' simplicity, this enzy.me is often 
referred to as coprogenase. 
Reaction (2) is thought to be cata.l.yzed by a 
eparate enzyme protoporpl:qrinogen oxidase (346). 
·dence for the two enzymes is presumptive , ho ever, 
as neither has been isolated in the absenoe of t he 
other (346): 
Protoporpby:rin in nature is· always o:f the type III 
isomer and will, in th't· text to f ollow. be referred to 
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The activity of the C-6 carbon of the uric acid moleoule 
\ 
was not studied and this step was omitted completely. 
The manganese dioxide solution was very muoh more 
concentrated than the one described by :Bu.chanan (46). 
Initially, the uric acid/manganese dioxide solution was 
agitated at 38° C in 50 m1 conical flasks in a Dubnoff 
etabolio Sha.king Incubator (Precision Scientific co., 
Chicago) for 8 to 12 hours. This step was out down 
to 7 to 10 minu.t&a with the us of ultrasound (Sonifier, 
Branson Sonic Power, Branson Instruments Incorporated, 
Connect. u.s.A.). 
To teat the extent of degradation, urea estimations 
were performed on the supernatent obtained fol1owing the 
lead precipitation step. The amount of urea present in 
the sample at this stage was ofte close to 5~ of the 
ma.x1l!twn amount theoretically obta.i?lable. 
1 m mole of uric acid ,f complet ly degraded, should 
give rise to 2 moles of urea and l m mole of glyoJcylio 
acid semicarbazon. The usual yield (corrected to 1 
m mole uric acid) was about 2./3 m moles urea (as barium 
c rbonate) and 1/3 m moles glyoJcylio acid as the semicar-
bazone. In later experim~nts where 2 m moles of uric 
acid ere d .gra.ded,amounts of barium carbonate and glyoxylic 
acid semioarbazone were o£ten over 250 mg and 60 mg respec-
tively, i.e. amounts that could be accurately weighed 
with enough radioactivity to give significant counts above 
background. 
(4) Combustion of organic awnple~. 
(a) General prinoipl s. 
30 6 
The following procedures deal with the determination 
of the specific activity of bilirubin and haem.in. hese 
organic substances, and others e . g. proto:porphyrin, 
stercob111n etc., oan be combusted to carbon dioJtide 
by heating with a chemica1 mixture of high oxidizing 
potential. Oarbon dioxide evolved diffuses across a 
vacuum and is trapped in co2 - free sodium bYdroxi<ie 
and counted as barium carbonate . The total weight 
of organic sample oombUsted should give rise to about 
li m moles of 002 i . e .• equivalent to about 300 mg barium 
carbonate . 
ith haem.in, the weight combusted is about 30 mg, 
which gives rise to adequate amounts of co2• However, 
with biliru.bin 0.1 mg or less is al1 that oan be isolated 
and as a consequence unlabelled or 'cold" glycine 18 
usual.ly mixed with the sample to produce sufficient carbon 
dioxide . 
In oa.l.cu1ating the specific activities of the original 
sample, the following point$ must be borne in mind . Wher e 
the entire sample oombusted is radioactive ( . g. haemin) , 
the activity of the isotopic carbon in barium carbonate is 
equivalent to that of each of the thirty-f our carbon 
atoms of the haemin moi ety. However, when carrier is 
added, e.g. glycine to biliru.bin, not only must the exact 
wei ght of the bilirubin be known, but th total barium 
oa.rbona.t obtained must b aec rtain d, the latt r, as 
ne st determi.ne the total specific activity coming 
erom tha.t accurately known weight of bil.irubin combusted. 
The method to bed scribed is bas don th one 
used by van Slyke et al ( 449) , 
(b) Reagents, 
( 1) Make mixture of Kio3 and K2cr2o., :tn th 
proportion 2sl. Grind with a mortar and pe tle to mix 
thoroughJ.y. 
{ii) Liquid reagent: 67 ~I fuming H2so4 
33 "'' H3PO 4 
lg KI03 
Hat to 160-180° C till no3 has dlf solved,. Keep 
dust 
free. 
( i ii) CO2- fr e NaOH. 
First make a quantity of co2- tr distilled ate~ by 
boiling ter for approx. 3 hrs . Store in an a&pirator 
bottle, closed with a rubber bung complete with drying 
tube containing. indicator soda lim. a aa.turate . 
solution of NaOH using th above CO2 free at ('t- 20 N) . 
-
Stor in a inch ster bottle with a siphon p1:oteoted by a 
drying tube with soda lim. 
To make the l N aOH used in the method, sufficient 
-zoo 
.J l > 
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(d) Yield of ba~ium carbonate-effioienoz of combustion 
and the collection of co2 evolved. 
One m1J.l1mole of haemin (ferrihaem chloride) has 
34 illiatoms of carbon. As the molecular weight of 
haem.in is 652 (651.969) and that of oarbon 12, it ean be 
cal.oulated that 408/652 1.e. 62% of the weight of haemin 
can be accounted for by its carbon content. 
As the moleoular weight of Baco3 is 197, the total 
eight of carbon evolved from the combustion of haem.in is:-
BaCOJ x .1.~ 
197 
This• expressed as a percentage of the eight 0£ haemin 
combusted should be 62.7% if both the combustion and the 
technique for trapping and collecting the evolved co2 are 
100% efficient. 
50 ran om sucoessive valu 
values ere b tween 59.5 and 63.5 
ere oalcul.ated and most 
ith a mean of 61.9%. 
Thus the average loss of carboQ. during the whole procedure 
as n.ly l.28%, i,e. an efficiency of a high order. 
Thia efficiency is not important wh~re the whole 
compound combusted is isotopic e . g . haem.in. How ver. 
when minute quantities o~ an is topic ~garde com ound, 
e . g. bilirubin plus carrier e . g . glycine, are oo~busted, 
the total activity evolved must be measur d (aee section 
(a) above), The accuracy of measuring c14 activity in 
bilirubin is dependent therefore upon a virtually 100% 
3 1 I 
yield of Ba o3• I feel that the combustion method f'ulfilS 
these needs adequately. 
( 5') De;te;tnin&tion ot, specit;L,p a,cti.'11.R{ of segum bi,l1tubin. 
Two methods of isolating bilirubin from serum have been 
employe in t l is study. The first 1s modified frqm the 
extraction and crystallization procedu1•e r ported by Ostrow 
et al (331} and the second is identical to that used by 
Yamamoto et a.l (498) and Israels (208). 
In the for er method , the concentration of bilirubin in a 
known volume of serum is estimated, a known amount (approxi-
mately 1 to l mg) o:f carrier bilirubin is added and the 
concentration of the ca.rrier- se ,m mixture is determined. In 
this way , the xact dilution of serum bil1rub1n by the added 
carrier can be ca~culat .d. Biliru in ls then extracted from 
the aeidified ·plasma into ether, recrystallized rom chloro-
form and then from dry methanol Rnd a known weight is combusted 
to carbon dioxide which is counted as barinm carbonate. In 
the procedure described by Yamamoto, Israels et al (498 , 208} , 
bilirubin is extracted from serum into chloroform and adsorbed 
on to an aluminium oxide column. It is washed , eluted with 
ehloroform, its eoncentration s d ter ihed s9ectro-
photometrically and a known volume is AVapor-ted to dryness in 
14 a combustion tube , here, after combustion to o2, activity 
is counted as barium carbonate. The yield fro this method 
is only 15% compared to the 25 to 30% yield by the procedure 
or Ostrow et al, but it has the advantage of being simpler 
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and, as t here is no dilution of the "hottt serum bilirubin by 
'cold" carri9r, i accuracies 1n the azobilirubin assay of 
serum bilirubin will not influence the final result. 
(a) ollection of specimen. 
Approximately 40 1 of heparimi ed blood is taken into a 
"Lusteroid" tube sealed with a plastic cap and is centrifuged 
in a refrigerated centrifuge at 10 ,00 r pm for 10 minutes , 
• Serum is separated and stored in the dark a.t -15 C if delay of 
more than one hour is anticipated as serum bilirubin is 
unstable in light at room te poraturo. 
(b) Bilirubin carrier. 
About 100 ml of pooled human serum is cleared by centri-
fugation at 10 , 000 rpm for 20 minutes and passage through an 
OSWP ( lOmu) millipore filter (B. D. H; ~illipore filter corp. 
Hass . U. S.A.). 5 g of bi lirubin (B. D.H . ) are weighed into 
a 50 ml beaker ~rapped in alum1n1um foil to exclude light. 
The bilirubin is dissolved rapidly in 7. 5 1 of o. 5 N aOH 
with gentlG swirling. Immediately it has g0ne into solution , 
20 ml serum and 3. 5 ml of 0. 1 Her are added in this order . 
The contents of the beaker are transferred to a 10 ml 
vol umetric flask which is ade up to the ark with ser • 
Solution is then stored in a dark bottle in the deep freeze . 
< c) ea gents. 
( i) eqgents for azobilirubin assay of serum bilirubi n. 
affeine mixtures affeine 100 gm , sodium benzoate 150 gm, 
sod1wn a~etate 250 gm, made up with water to 2L in a 
volumetric flask , 
Sulphanilic acid solution; Sulphanilic acid 5. O gm, 15 ml cone . 
HCI made up to lL with distilled water. 
Sodium nitrite solution: Prepare stock solution of 25% Analar 
sodium nitrite in water. Dilute 5 times (i.e. 0.2 ml or 
stock solution+ 9.8 ml water) immediately before use . 
Diazo reagent: 0. 25 ml or , 5% sodium nitrite+ 10 ml sulphan1lic 
acid. Make fresh reagent each day and use within 30 minutes 
of preparation. 
Ascorbic acid solution: 200 mg ascorbic acid are dissotved in 
5 ml water . Make fresh sol ution each day. 
Fehlings solution: 100 gm. aOH, 3 0 gm sodium potassium 
tartrate, made up to l litre with distilled water, 
<11 > R~agents yseg in extrac.tton bilitybin ft.9m ser;wu. 
Dry methanol: prepare as in Vogel pg. 164 (452) . 
Peroxide free ether; first prepare follo . ng solution. 
Ferrous sulphate 6 gm, cone H2S~ 6 ml , water 110 ml. 
Shake lL of ether with 20 ml of t his solution and thereafter 
wash once with water . 
least eve-ry two days , 
Ether ust be cleared of peroxide at 
(d) Procedure fQt.J!SSgY of 1}1l!ry.bin in serum. 
Allow plasma sample and bilirubin carrier solution to thaw 
in th~ dark in warm water. 
To 2 ml of the plasma sample add 3 ml water and mix (i,e. 
prepare 5 ml of a 4:10 dilution of plasma) . 
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If the plasma is haemol;rsed make a 1:1 dilution. 
-1easu e volume of remain er of plas a. and mix with 3. O ~l 
bilirubin carrier solution to give mixtur~ fore traction. 
Set this on one side ~~th exclusion ,r Jight. 
To . 5 ml of carrier- plasm ixture , add 4. 5 1 water 
( i . e . prepare 1 : 10 d11:dltion of mixtur-e) . 
-Prepare 5 ml of 1. 25 d·1 ttol1 of the c· ier solution by 
adding 4 , 8 ml of 1:25 dl uti0n of' -the car.t'ier solution by 
~dding 4,8 ml of water to 200 ul of the standard . 
et out 2 rows of 6 te t tubes in aach iOW and ~ake 
additions as indicated in the tab e below. The front row 
represents the test solutions and the back row the ulanks . 
The assay is carried out in duplicate . 
The contents of each t, be mixed and rad on a ~pectro• 
photometer t 600 mu slit rld th O, 5. 
l 2 3 4 5 6 
Plasm.a 1 ml 4/1 .. 1 ml 1/1 .. 1 ml 1/25 
-test mixture carrier 
Ca feine 2. 0 2. 0 2 . 0 2. 0 ~. 2. 0 (ml) 
Diazo (1 . 5 0. 5 c. 5 . 5 '• 5 c. 5 
ea ent ,..,,n$ (ml) Wait exactly 10" for c , lour to evclop. 
Ascorbic 
c1d (ml) . 1 0. 1 0. 1 0. 1 . 1 ( , 1 
Fehlinfs 1. 5 1. 5 1. 5 1. 5 1. 5 1. 5 
olution 
(ml ) 
Pl a 1 ml 1-/1 
-
l 1 1/10 1 ml 112, 
test 1ixture carrier 
7 "\ 
Calculations: · · 
fotal mg biliru.bin per 100 ml plasma= 
ean readip.g of tes't - mean reading o:r blank x 43 
Dilution of plaa a 
Total mg bilil"Ubin per 100 ml plasma-oarrier mixture= 
ean read~ ci'· t 'est· - mean re·ad;!-pg of blank x 43 · · 
Dilution of plasma-carrier mixture 
Total mg biliru.bin per 100 ml carrier solution= 
Mean read!As o~ test~ m~an reading of blank x43 · 
Dilution of carrier solution 
is Accuracy of assay~checked by comparing carrier con-
coneentre.tion of bilirubirt as determined directly and as 
determined indirectly from difference between plasma 
alone and plasma+ carrier mixture . 
( This method is modified from the work of' chat!lson 
{296) . 
(&) Extraction of Bi'lirubin. (331) 
. ,, 
Serum-carrier mixtur~ Abrought to pH 5. 0 with 0. 3 
IA,.$1111 M Acetate buffer (pH 5) at- pH meter. 
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Bilirubin extracted in 250 ml separating funnel with 
repeated small volumes of peroxide-free ether until all 
the yellow colour extracted (usually l L peroxide-free ether 
is required for complete extra.otion. 
Fxtracta pooled in al L separating funnel covered with 
brown paper to exclud light and ashed five times with 
approx. 100 ml portions of distilled water. 
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Ethe~ extract shaken vigorously with 5. 0 mJ. of 0 .02 · 
sodium pyrophosphate solution. The yellow pig,nent 
should be extracted completely into this l9'1er. If it 
is not , add 0 . 1 NaOB drop b1" drop until all yellow pig-
t:he. ment 1s extracted into aqueous phas . Repeat ,.. extraotion 
1th sodium pyrophosphate solution until clear. 
Q,-( Pooled pyrophoephat& extraots"added to 100 ml sepa-
rating funnel containing 1 ml gla.o1a1 acetio acid and bili-
rubin extracted repeate~ into small volumes of chloroform. 
Combined chloroform. extracts we.shed 6 times with wate:r, 
once with an equal volume of la% NaCl solution and 4 times 
with water. 
Filter chloroform solution through Whatman•s No . 40 
filter paper moistened with chloroform and evaporate 
filtrate to a small volume in an evaporating dish over 
th( boiling water in a be.aker. Transfer ,.. eonoentrate quanti tat•• 
Q. 
ly .to "gra.dua.ted oentl'ifuge tube and evaporate oft the 
remainder of the chloroform under suction until crystals 
just begin to form. 
Add 2 volumes of dry methanol and continue evaporation 
slowly until bi11rubin crystalliees ou~ as orange needles . 
Separate by centrifugation and remove supernatant fluid 
with a Pasteur pipette. Wash oryatala ith 0. 5 ml cold 
d::ey- m thailol . Oentritu.ge, deoa.nt methanol and dry crystals 
in vac~o over silica gel and pa.x-affin wax shavings . 
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Recrystallise bilirubin by dissolving in a few ml of 
chloroform, evaporating down and adiing i volume of methanol 
as above . 
Dissolve crystals in a few m1 of chloroform and run 
o~o 1 x 2 om columns of aluminium oxide . The bilirubin 
is absorbed aa a thin lay r on the top of the column. 
Wash repeatedly with chloroform to extract all fatty 
material and finally elute bil1ru.bin usiDg a solution of 
11, acetic aoid in chloroform. 
Transfer eluate to 250 ml separating tunnel and wash 
repeatedly with distilled water until neutral. Reorys-
tallise bilirubin from chl.oroform solution after eva-
poration as above . 
Dissolve final 01:7sta.ls in about 3 ml chloroform and 
transfer to combustion tube . 
easure volume of solution and transfer to combustion 
tub • easure biliru.bin concentration in solution by 
reading 0 . 1 ml of solution+ 2. 9 ml chloroform. in 
stoppered ouvette against chloroform blank at 453 mu in 
spect.rophotometer. 
Calculations: 
~otal bilirubin in combu tion tube= volume of soiution x 
:Beokman reading x 
0 . 28896 
Evaporate chloroform in combus'tion tube . Ad ap:proxi-
mately 40 mg glycine to combustion tube to provide 
oarrier co2, eo bust a.nd harvest barium carbonate a.a 
usual. 
(6) Estimation of Speoi~io Activitl of Plasma Bil1rubin 
(Alteniate M thod} t 
This method 1a ba ed on p rsonal communication with 
Israels (208) and rom paper by Yamamoto t al (498) . 
(a) Prooedur • 
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(l) To 10-25 ml plasma dd o.18 vol of (mt4)2so4 
,solution ( satumted at room temperatur ) and 2. 5 vol.s of 95% 
thanol. 
(2) Stand overnight 111 refl"igerato:r (4°c ) and centrifuge 
at 10,000 r . p.m. tor 10 min. 
( 3 ) Decent aup ma:ta.nt d to it add :further 2. 5 x o gina.l~ 
volume of 95% thanol to s cure complete precipitation 
of prot 1n. 
(4) Stand for l hour at 4°0 and centrifuge at 10,000 
r . p~m. for 10 min. 
t~ (5) Add approx. 100 mg aaoorbio aci toAethanol auper-
nate and take to dryness in rot ry va.porator (N.B. !l?em-
perature not >40°0) , 
(6) Dissolve reai ue in chloroform and ilter on to 
1 x 2 cm column of alwainium oxid . :Silirubin 1 
~ 
. absorbed as~yellow band at top of column. 
(7) ash column with 50 ml chloroform and elute bili-






\ f\' "' 
I ~ f ' 1 
(8) ash eluate .3 times 1th di tilled water and filter 
through chloroform moistened filter paper into 10 m1 
graduated measuring cylind r. 
(9) Read ovt;ioal density in Beckman (DB Spectrophotometer) 
at 453 mu aga.1:nst ohl.orofonn blank (= R). 
(10) Return cont nts of ouvette to measuring cylinder and 
record volum (= V). 
(ll) Transfer contents of measuring cylinder quantitatively 
to combustion tube and evaporat to dryness . 
(12} Add approx 40 mg glyoine (to provide carrier 002) 
and oombust . 
(13) Harvest Baco3 quantitatively and ooun • 
Oaloulationt 
S.A. of b1lirub1n (dpm/lllg - pm x 103 n--x- , -,---g .... -,-1 
A suming E mol for biliru.bin in chlorofom. ot 6 x 104 
(296) . 
(b) Comments on methods (5) and (6) for measuriy 
' 
plasma b111rub1n- o14 activity. 
$ 
A nUtnber of difficulties beset any- method of measuring 
plasm.a biliru.bin-014 activity follo ing glycine-2-014• 
Pirstly, even at peak vaJ.uea, th isotopic activity of 
bilirubin is only a few hundred counts per minute/mg. As 
normal plasm only has about o.; bilirubin/100 ml and as 
the 20 ml of pJ.aema obtained ha.a, therefore, approximately 
o.l mg per 100 ml, one is working with minute quantities . 
3zn 
' 
( • ) . 
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Pathologists ( 408) • Six highly purlfi d oomm.eroial and 
2 privately purifi d crystalline pr pa.rations were 
tn.easured in triplicate by 3 differ nt laboratories 
and ga'\',.e a J. om molar a.bsorptivi ty of 60 • 700 ! 800 
326 
(mean+ 1 standard deviation) hen dissolv din chlo:rofor.m 
-
and read at 5.3 I!iU at 25° c. the collDllitte recommended as 
acceptable a bilirubin ample giving a molar absorptivi·lir 
of betwe n 59,100 a.nd 62.300. 
To calculate the total amount of biliru.bin in the 
combustion tube • both an aoourate a.s ey and the volume 
of the olution at the· time of assay must be known. 
Usually, the bilimbin so1ution is pre ent in a finely 
graduated test-tube (from hich volume can be read) before 
transferring to a. combastion tub. 0 . 1 ml of this 
solution is added to 2. 9 ml chloroform and the cuvett·e 
stopper ed, thus ma.king al in 30 dilution of th biliJ'llbin 
solut1once As ,oo. 00 mdlitre (approximately molax- solution) 
ould read about 60 1000 on the spect~ophotometer• 0. 1 mg 
biliNbin/100 ml ohlorofonn would have an optioal density 
of about 0 . 1 . iore accurately, a reading of o . l would 
be equiva1ent to 584/607 x 0 . 1 mg/100 m.l i . e . 0.()9632 mg/100 
ml ch1oroform. 
From the above,, the cal.cuJ.ation fonnula. 1· a.a followe: -
(a.) Reading x 0 . 9632:;:: no mg biliru.bin/100 ml ollloroform 
in assay cuvette . 
'\ l 
·3R7 
\ \~'-- - -
(b) Reading (R) x 0 . 9632 x 30 (i.e." Rx ··0 . 28896)= 
mg bilirubin/160 ml chloroform in 
combustion tube . 
\ 
' 
(c) Volume (V) x reading (R) x 0. 28896 i.e. VR x 0. 28896 
= Total ei{;ht of bil.iru.bin to be 
combu ted. 
The standard oalibration ourve measuring known amounts 
o:f biliru.bin (lIDH) is chloro£orm as a straight line in · 
the range of onoentrations enoouutered during eXperimental 
procedures (See fig. 6-7) . 
(7) Isol.a.tion and.purification of_haemin, 
This rather straight forward ~solation procedure 1s 
derived from a method described by Labbe et al (236) . 
{a) Reyentsa 
(l) 2'fo sr012. 6B2o in glacial a.cetio acid. 
(2) Acetone (Anala.r) . 
(3) orking solv nt: One part of (l) + thne parts 
(2) prepared immedia,tely before use . 
(4) Pyridine (Analar) . 
(5) OhJ.orofo:rm (Analar) . 
(6) Acetic acidt ater (1:l) . 
(7) Ethanol 96~. 
(8) her (Analar) . 
(b) Procedure: 
io l volume of blood or lysed red cells add, with 
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Stand for 20 mins with occasional stirring~ . ·· Heat 
to ooi1ing point briefly during this period of standing to 
increase protein rocipit tion. 
t .. t Filter and ashAresidue on filter papar twice ~ith 
l volume of solvent . 
ore. Pooled filtrates~heated to 100°0 with a boiling chip 
in a beaker. Stir it thermometer and do not al1ow 
temperature to exceed 102°c . 
Crystallisation begins hen the solvent concentrates 
and is complete on oooling to room. temperature~ 
Harvest crystals by filtration (Hirsoh funnel) and 
wash twice with 5~ acetic acid in water, once with ethanol 
and once with ether. 
Receystallise by taking up in minimum amount of 
pyridine and chloroform. 
1lter and add 2% sre12 in acetic acid . 
100°0 and al.low to cool. 
Heat to 
Harvest erysta.l.s e.nd ash as before . Dry in vacuum 
denicator over silica gel. Weigh acourately into 
combustion tubes for countillg as barium carbonate . 
(c) Comment, 
Yield ldter recrystallisation - approx. 6<>,£. 
Thus, starting with about 8 ml of packed celle about 
30 mg 0£ purified haemin were obtained for oombuetion. 
( 8) . ea.surement of . radioactip;lt •re ~,··::,. 
The radioactivity of samples from all the uric aoid 
degradation experiments and two of the biliru.bin~o14 
33 C 
studi s was measured with a Packard Tri-Carb Liquid 
Scintillation Spectrometer. For the remaining b111rubin-
o14 experiments • all measurements of radioactivity were 
made with the :Seckman Liquid So:intillation System_. 
Urie aoida glyo:x;ylio a.oid emica.rba.zone and barium 
carbonate were weighed accurately into counting vials. 
and suspended in a scintillator of th following composition: 
2,5 - diphenyloxa~ole (PPO), 0.3 gntf 1 14 - bis - 2- (5 
pheey-loxazole) ... benzene (FOPOP). 0 . 03 gm; Oab - 0 ... Sil 
(Packard) , 4 .• o gm; toluene 100 ml. 
J?relim.ina.ry experiments indicated that there was no 
self-absorption of the soft P-emissions over the range 
of weights used in th oounti via.ls . The efficiency 
i th hich the Paokarcl ri-Ca.rb counter and th 
Beckman Liquid Scintillation count r detected c14 in the 
va.i"'iou samples aa about 53 to 57~ and 65 to 68% respec-
tiv l.y. The ef:f'ioi noy of counting every ba.toh was 
eteJ. ined by adding a known number of dpm as n-Hemdeoa.ne-
1...014 (!rho radioohemica.l centr, .Amersham, Bu.okinghamshire, 
Engl d} to several plea . The radioactivity of the 
samplea counted (c. p.m.) was thereby accurately converted 
to disintegrations per minute (d.p. m. ) Radioactivity of 
the individual samples as expressed as d. p .m. or as 
331 
- --· - ,..,, ---- # · · -- - - - ·- .,... __ .., • • ---













1 • 3 




4) + + ::, 
'<t N u u u 
'¢ 4) 
• • • ,.... 0 I \ E 4) 
• l / •• I . """"I N . • :::c • \ ,.... Q \ 
------· 
• • u 
. ·~ . I < 0 • ,.... u / / I a::: 
• • • I :::> I 
• - co z 
-~ 
• \ V) 0 >-.. 
• • • 0 t- / / I w Q a::: 
• • • - -0 u I I I X w 







./ \ Q 
• • / / 






N co '¢ 
N ,.... ,.... 
£-·ol X Al!DP asop % 
: : . 
33Z 
% dose X 10 - 2 
__, 
__, ts..) 
0 ~ (X) ts..) 0,.. 0 
0 
I ••• 
. \ \ '-. () ts..) • • • 
C \ ~ 
• • • C \ r-)> ~ • • • 
-i \ \ -< • • • m \ \ m 0,.. • • • >< CJ \ () 0 
• • • :::cJ 
'< \ m VI 
-i (X) • • • 0 
z • • • 
' \ C \ __, 
:::cJ 0 • • • 
-l \ () 
• • • )> \ () __, 
• • • -
ts..) 
CJ \ ~ 
:;-
• • 0 • \ (b \ 3 __, 
• • 0 • ~ () () (b 
n Iv 
,I:,,.. C + + (b CX) VI 



























-0 'q' 0 
8+2'::>; 
q+t) 
:r:t.g. 7-3• J.y 04+5• 02 aroun4 
mean+ 
·-

































J: • • 
0 0 0 0 0 0 0 CX) -0 "<t N 
a1n=>a1ow 1oio1 % 
ttg. 1-4• l>iepoetti n of radioao'Civit7 withilt 
Urio aoid lll.Oleou.l I daily ve.lu•e 
around ean, 1n nonnal., H.J. 
339 
34 0 














































1 - , - T - - - 1-- 1 .-
0 
-0 N co N ..... 






































ts. 7-5~ Th dailg inoorpo:ra.tion .of elJ' in 2-014 
1n o urinary uric acid• 04+5 and 02 · 
in no • A .. l. 
ii 



















a, II) GO 
0 + + E "<t N 
~ u u , ;s: • 0 • • 
..L:. 
~ 
• • • \ 
• • • 
_ N 
-
• • • \.-
• • • 
- 0 
-
• • • 
• • • - co I I II) 
>--
• • • i 0 Q 
• • • ,0 
• • • 




















~h ownulat1v · ii.Loorpo 
1n'to urinary uric .oi , 
nonaJ., .,J .. 
0 
tion o glqcine-2 































































• • . 
4: l--+O I I I I I ·- r 
0 0 0 0 0 0 
0 CX) -0 -..:i- N 
a1n:>a1ow 1°i01 % 
Pi• 7-81 Dispo ition .ot ra41oaot:l: t7 within ur1 
acid mol cul• daily v nes around man, 

















- • • 
7 ,. :t r 3 • (t • 
7-7) 






~ . ' , ' ! • ; l,,. • 35 ·J·' 
<I) 
:::, I.{') co V 
+ + ~ 
0 "<t N E u u 
"q' • • • ~ I I .-0 ..c ~ . • • 
. / I I 
• • N I I I .-0 
u • • • I \ . <( 
• • • 0 u 
"" 
\ .-e:::: 
• • • ::> I I I 
z • • • CX) 
0 ~ \ \ V') >.. t- • • • 
./ / I 0 w 0 e:::: u • • ,0 
X I \ \ w 
• • • 
>- ~ \ ...J 
• • • <( I / / 0 





~ . \ . <( 
0 I 
N 0 CX) ,0 "q' 
.- .-
OL X asop % £-
l1g. 7.gt the 4e.t]¥ inO:fOl:'a: 1011 ot giye1ne-2-c14 
int urina17 . 1 C4+' ca.a 
1n normal• A · • 
352. 




LI") co Q) 
0 + + 
E "<:I" N 
Q) u u ~ • • • .... 0 \ ..r. ~ 
• • • \ 
N • • • 
\ 
.... 
• • • \ 
0 
• • • .... 
\ 
• • • 
w \ 
> • • • 00 
I- \ II) <( >,.., 
• • • 
--' \ 
0 
:::> 0 ~ • • • '° :::> \ u 
• • • 
\ 







0 0 0 0 0 0 0 N 0 00 
'° 
~ N 



























Daily 04+5: 02+8 ' tio c tt 


















d ound an 












i V, I >-. 




• • ' 
Q) 








. I ~ • • I . I < I 
r--· i 0 
0 0 0 0 0 0 
0 CX) -0 ~ N 
a1n:>a1ow 10~01 % 
1111 7-12• Di Po tt1on of radio tivity within uric 
aoi4 mol oul , dally v: u around me t 















' .. 357 
4 





% dose X 10 -J 
_. 
0 "-> J::,... 0,. (X) 0 
o ' 
\~ ::::0 . 0:, . 
"-> • • 
J \ \ 
• • I \ i I J::,... 
• • I I 
• • I I 
0,. • • 
~ · 

















7-13• T daily 1no rporation o glycin - 2-014 












. r :! al • . 
0::: 





• ~ Cl) >-. 










0 + (f I . - ) 
13. SYMPTO TIC PORl?HYRIC SUBJECTS . 
{1) - A .• A. 
(a.) Evaluation of ex»er?,Illental findipSs ., 
. 
-- - ·--
A.A., a 46 year-old Oape Coloured ma.le, had akin 
lesions of porphyr.1a for 7 years . He as a chronic 
alcoholic subject with clinical and biochemical evidence 
of liver failure . Liver biopsy showed increased iron 
pigment, hepatocellular damage 1th regeneration b)tt no 
fibrosis . He had a normal sto l porphyrin content but 
excreted excessive amounts of uroporphyrin {6392 ug) and 
copropor:pb.yrin ( 528 ug) in the urine daily' , He was there-
fore a classical case of symptomatic porpbyria. 
Renal tu.notion was good (ereati nine clearance 142 ml/ 
min. ) and his haemoglobin 15~4 gm/100 ml~ 7 serum uric 
acid levels ranged between 3. 65 and 5. 92 mg/100 ml during 
the course of the experiment . 
V!II diabetic diet 
He was placed on a step 
24-hour urinary urate excretion ranged between 471 
and 639 mg of which more than 400 mg puri f i ed uric aci d 
ere usual ly obtained. Thus adequate amounts of isotopi c 
urio acid ere available for degradat i on and counting and 
generally more than 50 mg glyoxyli c acid semicarbazone and 
100 mg barium carbonate ere obtained for counting. 
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lower incorporation values observed in z. ! . {See :previous 
chapter). 
The above oa.se e=emplif1es the importa.noo of knowing 
what percentage of the total urate eliminated, is excreted 
by the kidney and what the rate of turnover of the urate 
pool is at the tim ot study. 
It is not known why sym tomatic porphyric incorporate 
a greater portion of the administered glyoine-2-014 into 
~ 
urina :\trio aoid, C4+5 and 02+8. It is likely that 
owing to an int.rrdhepatic obstructive difficulty in 
excreticn cf uric acid via the bile in aympto a.tic porphyria, 
rel tively more urate is elim.i ted vi na1 channels , 
thus accounting for the high r valu s. This again em-
phasizes the im.portanoe of correcti for xtrarenal 
urate excretion in isotopic glycine incorporation studies . 
Ev n if tho corrected incorporation of yoine-2-014 
into urio aoid, 04+1 and 02+8 were known, there is still 
the possibility tat any chang s due to a disorder of 
liver purine syn·Lhesis in acute human porphyri y be ma.eked 
by normal. purine metabolism in other tissues. The importance 
of the liver in body purine metabolism a a who1e has been 
repeatedly stressed in earlier ch pters (see Chapter IV, 166 
seotion c 3, pages 16Jl.1/ section EJa, pages 17 o 186 ; 
section Hl(b), page 207 ). Basically the liver is rich in 
nucleotides and nucleic acids with a rapid r ate of turnover 
463 
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In Chapter IV, :pages 215 J;o 219 , the rapid tu.mover of 
the glycine pool was stressed. Th emerged the 
eoncept of a 1ngle "pulse" of activity in the body 
following the administr-tion of label d gl_ cin reaching 
peak values well within 24 hours and of little magnitude 
after 48 hours , Thus isotopic uric acid will be derived, 
i' ... 
I ' 
1n them in, f.!.om :purine compounde synthesized mainly within 
the first 12 to 24 hours of inj cting glycine . 
Follo ing the admin1st tion of blycine-H15 (see Cha:p-
228 
ter IV, pngos 226/ for details) any enrichment of 
aspartic acid or glutamine will be derived from that N15H3 
arising from the oxidative deam.in tion of glycine . One 
ould expect that tl1e first isotopic purine moieties 
elaborated ~ould :1avo most w15 activity in U-7 (from 
gl cine) w'rllst thos made lat r woul.d have an increasing 
proportion of th tot 1 mol cul 's activity residing in 
those ·trogon atcms derived fro aspartic acid and 
glutemine i •• N1+3+9 . Gut i; al (168,170), Shemin 
et ·l (413) and no oll et al (196) all demonstrated quite 
clearly t.wt with time , Nl+3+9 comprised a progressively 
gre~:ter percentu.ge of the total maecular-N15 activity 
(see Chapter IV, pagea227 and 228) . Thus, the 
changing disposition of N15 activ1.ty within the uric 
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